Caseware UK (AP4) 2024.0.164 2024.0.164 2025-03-31 2025-03-31 The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.true 2024-04-01 false No description of principal activity 1 1 true false 09747342 2024-04-01 2025-03-31 09747342 2023-04-01 2024-03-31 09747342 2025-03-31 09747342 2024-03-31 09747342 c:Director1 2024-04-01 2025-03-31 09747342 d:OfficeEquipment 2024-04-01 2025-03-31 09747342 d:OfficeEquipment 2025-03-31 09747342 d:OfficeEquipment 2024-03-31 09747342 d:OtherPropertyPlantEquipment 2024-04-01 2025-03-31 09747342 d:OtherPropertyPlantEquipment 2025-03-31 09747342 d:OtherPropertyPlantEquipment 2024-03-31 09747342 d:CurrentFinancialInstruments 2025-03-31 09747342 d:CurrentFinancialInstruments 2024-03-31 09747342 d:Non-currentFinancialInstruments 2025-03-31 09747342 d:Non-currentFinancialInstruments 2024-03-31 09747342 d:CurrentFinancialInstruments d:WithinOneYear 2025-03-31 09747342 d:CurrentFinancialInstruments d:WithinOneYear 2024-03-31 09747342 d:Non-currentFinancialInstruments d:AfterOneYear 2025-03-31 09747342 d:Non-currentFinancialInstruments d:AfterOneYear 2024-03-31 09747342 d:ShareCapital 2025-03-31 09747342 d:ShareCapital 2024-03-31 09747342 d:RetainedEarningsAccumulatedLosses 2024-04-01 2025-03-31 09747342 d:RetainedEarningsAccumulatedLosses 2025-03-31 09747342 d:RetainedEarningsAccumulatedLosses 2024-03-31 09747342 c:OrdinaryShareClass1 2024-04-01 2025-03-31 09747342 c:OrdinaryShareClass1 2025-03-31 09747342 c:OrdinaryShareClass1 2024-03-31 09747342 c:FRS102 2024-04-01 2025-03-31 09747342 c:AuditExempt-NoAccountantsReport 2024-04-01 2025-03-31 09747342 c:FullAccounts 2024-04-01 2025-03-31 09747342 c:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 09747342 e:PoundSterling 2024-04-01 2025-03-31 iso4217:GBP xbrli:shares xbrli:pure

Registered number: 09747342 EXECUTIVE HEALTH CONTROL LIMITED UNAUDITED FINANCIAL STATEMENTS INFORMATION FOR FILING WITH THE REGISTRAR FOR THE YEAR ENDED 31 MARCH 2025
EXECUTIVE HEALTH CONTROL LIMITED REGISTERED NUMBER: 09747342 STATEMENT OF FINANCIAL POSITION AS AT 31 MARCH 2025
|  | 2025 |  | 2024
Note |  | £ |  | £
Current assets |  |  |  |  |
Cash at bank and in hand | 5 | 382 |  | 538 |
|  | 382 |  | 538 |
Creditors: amounts falling due within one year | 6 | (1,200) |  | (1,200) |
Net current liabilities |  |  | (818) |  | (662)
Total assets less current liabilities |  |  | (818) |  | (662)
Creditors: amounts falling due after more than one year | 7 |  | (89,393) |  | (88,167)
Net liabilities |  |  | (90,211) |  | (88,829)
Capital and reserves |  |  |  |  |
Called up share capital | 8 |  | 100 |  | 100
Profit and loss account | 9 |  | (90,311) |  | (88,929)
|  |  | (90,211) |  | (88,829)
The director considers that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006. The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements. The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities. The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. The Company has opted not to file the statement of income and retained earnings in accordance with provisions applicable to companies subject to the small companies' regime. The financial statements were approved and authorised for issue by the board and were signed on its behalf by:
Ryan Lukas Farhad
Director
Date: 5 December 2025
Page 1
EXECUTIVE HEALTH CONTROL LIMITED REGISTERED NUMBER: 09747342 STATEMENT OF FINANCIAL POSITION (CONTINUED) AS AT 31 MARCH 2025 The notes on pages 3 to 6 form part of these financial statements. Page 2
EXECUTIVE HEALTH CONTROL LIMITED NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2025 1.Accounting policies
| 1.1 | Basis of preparation of financial statements
The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with FRS 102 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland' and the requirements of the Companies Act 2006. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view. The following principal accounting policies have been applied:
| 1.2 | Revenue
Revenue is recognised to the extent that it is probable that the economic benefits will flow to the Company and the revenue can be reliably measured. Revenue is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. The following criteria must also be met before revenue is recognised: Rendering of services Revenue from a contract to provide services is recognised in the period in which the services are provided in accordance with the stage of completion of the contract when all of the following conditions are satisfied: ∙the amount of revenue can be measured reliably; ∙it is probable that the Company will receive the consideration due under the contract; ∙the stage of completion of the contract at the end of the reporting period can be measured reliably; and ∙the costs incurred and the costs to complete the contract can be measured reliably.
| 1.3 | Borrowing costs
All borrowing costs are recognised in profit or loss in the year in which they are incurred. Page 3
EXECUTIVE HEALTH CONTROL LIMITED NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2025 1.Accounting policies (continued)
| 1.4 | Tangible fixed assets
Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management. Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives, using the straight-line method. Depreciation is provided on the following basis:
|  |  |  | Office equipment | - | 33% | Straight line
|  |  |  | Other fixed assets | - | 33% | Straight line
The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date. Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in profit or loss.
| 1.5 | Cash and cash equivalents
Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.
| 1.6 | Creditors
Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method. Page 4
EXECUTIVE HEALTH CONTROL LIMITED NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2025
2. | Judgments in applying accounting policies and key sources of estimation uncertainty
In the application of the company's accounting policies management is required to make judgements, estimates and assumptions about the carrying value of assets and liabilities that are not readily ascertainable from other sources. The estimates and underlying assumptions are based on historical experience and other factors that are considered to be relevant. Actual outcomes may differ from these estimates. The estimates and underlying assumptions are reviewed on a continuing basis. Revisions to accounting estimates are recognised in the period in which the estimates are revised. The key areas of estimation uncertainty that have a significant effect on the amounts recognised in the financial statements are described below: Accrued Expenditure The company includes a provision for invoices which are yet to be received from and amounts paid in advance to suppliers. These provisions are estimated based upon the expected values of the invoices which are issued and services received following the period end.
3. | Employees
| The average monthly number of employees, including directors, during the year was 1 (2024 - 1).
4. | Tangible fixed assets
|  | Office equipment | Other fixed assets | Total
|  | £ | £ | £
| Cost or valuation |  |  |
| At 1 April 2024 | 4,360 | 4,641 | 9,001
| At 31 March 2025 | 4,360 | 4,641 | 9,001
| Depreciation |  |  |
| At 1 April 2024 | 4,360 | 4,641 | 9,001
| At 31 March 2025 | 4,360 | 4,641 | 9,001
| Net book value |  |  |
| At 31 March 2025 | - | - | -
| At 31 March 2024 | - | - | -
Page 5
EXECUTIVE HEALTH CONTROL LIMITED NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2025
5. | Cash and cash equivalents
|  |  |  |  | 2025 | 2024
|  |  |  |  | £ | £
| Cash at bank and in hand | 382 | 538
|  | 382 | 538
6. | Creditors: Amounts falling due within one year
|  |  |  |  | 2025 | 2024
|  |  |  |  | £ | £
| Accruals and deferred income | 1,200 | 1,200
|  | 1,200 | 1,200
7. | Creditors: Amounts falling due after more than one year
|  |  |  |  | 2025 | 2024
|  |  |  |  | £ | £
| Director's loan account | 89,393 | 88,167
|  | 89,393 | 88,167
8. | Share capital
|  |  |  |  | 2025 | 2024
|  |  |  |  | £ | £
|  | Allotted, called up and fully paid |  |
|  | 100 (2024 - 100) Ordinary shares of £1.00 each | 100 | 100
9. | Reserves
Profit and loss account The profit and loss reserve is fully distributable.
10. | Related party transactions
| At the balance sheet date £89,393 (2024 - £88,167) was owed to Mr R L Farhad, the director and shareholder, by the company.
Page 6
EXECUTIVE HEALTH CONTROL LIMITED
THIS SCHEDULE IS NOT FOR PUBLICATION Page 7